Tenofovir
Protease inhibitors such as Boceprevir, Telaprevir,
Browse full report on Systemic Antiviral Pharmaceuticals Market -
http://www.transparencymarketresearch.com/systemic-antiviral-pharmaceuticals-market.html
Based on the disease type, the global systemic antiviral pharmaceuticals market can be analyzed as
herpes, hepatitis, influenza and HIV infection. Recent advancements in the field of antiviral treatment
for herpes infection have inclined the ophthalmologists to treat severe ocular infection caused by
herpes virus. In addition, the acute retinal necrosis (ARN) syndrome caused by herpes virus and
retinal infection caused by cytomegalovirus is also treated using systemic antiviral drugs. Vidarabine,
Acyclovir, Ganciclovir, and Foscarnet are the four major systemic antivral drugs used in the treatment
of ophthalmic infections. Rising incidence of herpes virus infections, as well as the rising epidemic
of HIV infections has led to increase in ophthalmic infections which drive the demand for systemic
antiviral pharmaceuticals.
Global Systemic Antiviral Pharmaceuticals Market: Geographical Dynamics
The demand for systemic antiviral pharmaceuticals is high in regions with high prevalence of herpes,
influenza, hepatitis and HIV infection. According to World Health Organization (WHO), worldwide
35.3 million people were living with HIV infection at the end of 2012. The prevalence is high in the
African region where nearly one in 20 adults is living with HIV infection. Further, the prevalence of
herpes simplex virus type 2 is high in Africa, North America and some parts of Asia-Pacific. Early
and effective treatment is therefore the primary need in these regions. Hence, the demand for systemic
antiviral pharmaceuticals will increase with growing incidence of viral infections.
Some of the major players in the systemic antiviral pharmaceuticals market are GlaxoSmithKline plc,
Bristol-Myers Squibb, Gilead Sciences, F. Hoffmann-La Roche Ltd., Pfizer, Inc., Boehringer
Ingelheim, Abbott Laboratories and Merck & Co., Inc.
Request for brochure of this report -
http://www.transparencymarketresearch.com/systemic-antiviral-pharmaceuticals-market.html
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global
business information reports and services. Our exclusive blend of quantitative forecasting and trends
analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team
of analysts, researchers, and consultants, use proprietary data sources and various tools and
techniques to gather, and analyze information. Our business offerings represent the latest and the most
reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals,
energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope
and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact